---
title: "GeneDx Holdings Corp. (WGS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WGS.US.md"
symbol: "WGS.US"
name: "GeneDx Holdings Corp."
industry: "Health Care Services"
datetime: "2026-05-20T05:50:44.277Z"
locales:
  - [en](https://longbridge.com/en/quote/WGS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WGS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WGS.US.md)
---

# GeneDx Holdings Corp. (WGS.US)

## Company Overview

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.genedx.com](https://www.genedx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:16.000Z

**Overall: C (0.43)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 38 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 34.09% |  |
| Net Profit YoY | -101.70% |  |
| P/B Ratio | 4.92 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1250756577.51 |  |
| Revenue | 442678000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -30.42% | E |
| Profit Margin | -17.58% | D |
| Gross Margin | 66.71% | A |
| Revenue YoY | 34.09% | A |
| Net Profit YoY | -101.70% | E |
| Total Assets YoY | 13.41% | B |
| Net Assets YoY | -1.27% | D |
| Cash Flow Margin | 11.97% | D |
| OCF YoY | 34.09% | A |
| Turnover | 0.93 | A |
| Gearing Ratio | 49.81% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - GeneDx Holdings Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "34.09%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-101.70%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.92",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1250756577.51",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "442678000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-30.42%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-17.58%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "66.71%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "34.09%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-101.70%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.41%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "-1.27%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "11.97%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "34.09%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.93",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "49.81%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.07 | 54/87 | 2493.42 | 2147.93 | 1761.20 |
| PB | 4.92 | 41/87 | 13.29 | 10.08 | 7.30 |
| PS (TTM) | 2.83 | 56/87 | 9.84 | 7.76 | 5.44 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **10**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 8 | 80% |
| Overweight | 1 | 10% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 42.13 |
| Highest Target | 100.00 |
| Lowest Target | 50.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/WGS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/WGS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/WGS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/WGS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**